Reshape Lifesciences Inc
(RSLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,946 | 3,007 | 1,907 | 1,576 | 2,167 |
| Receivables | 3,373 | 2,620 | 2,951 | 2,883 | 3,099 |
| Inventories | 2,095 | 2,244 | 1,988 | 2,080 | 1,257 |
| TOTAL | $8,250 | $8,944 | $8,150 | $8,545 | $8,508 |
| Non-Current Assets | |||||
| PPE Net | 718 | 584 | 431 | 99 | 12 |
| Intangibles | 26,612 | 27,022 | 27,424 | 27,841 | 28,257 |
| Other Non-Current Assets | 436 | 511 | 586 | 659 | 781 |
| TOTAL | $27,766 | $28,117 | $28,441 | $28,599 | $29,050 |
| Total Assets | $36,016 | $37,061 | $36,591 | $37,144 | $37,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,905 | 7,264 | 10,319 | 8,720 | 6,796 |
| Accrued Expenses | 4,017 | 3,630 | 3,257 | 3,009 | 3,499 |
| Other current liabilities | 390 | 397 | 383 | 315 | 171 |
| TOTAL | $21,632 | $11,605 | $14,268 | $12,347 | $10,763 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 3,204 | 3,434 | 2,763 |
| Other Non-Current Liabilities | 1,061 | 10,353 | 1,334 | 1,508 | 1,762 |
| TOTAL | $1,676 | $10,968 | $5,240 | $5,644 | $5,227 |
| Total Liabilities | $23,308 | $22,573 | $19,508 | $17,991 | $15,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,167 | 6,167 | 5,587 | 5,587 | 5,478 |
| Common Shares | 6 | 6 | 5 | 5 | N/A |
| Retained earnings | -519,701 | -514,827 | -506,291 | -501,112 | -497,508 |
| Other shareholders' equity | -101 | -120 | -73 | -28 | -55 |
| TOTAL | $12,708 | $14,488 | $17,083 | $19,153 | $21,568 |
| Total Liabilities And Equity | $36,016 | $37,061 | $36,591 | $37,144 | $37,558 |